Harry Jacobson
Co-Founder and Managing Director @ Epiphany Health Ventures
Nashville, United States
Harry Jacobson is a seed investor at Epiphany Health Ventures in Nashville focused on Music and Mobile. Prior to co-founding EHV, Jacobson was Vice Chancellor for Health Affairs at Vanderbilt University (CEO of Vanderbilt University Medical Center (“VUMC”)).During Jacobson’s tenure, VUMC revenues grew from approximately $750 million to $2.5 billion; its Federally funded (NIH) research program moved from twenty-fourth to one of the top ten in thecountry; it opened over $1.0 billion of newly constructed facilities; it was recognized as a “most-wired” hospital as well as a U. S. News and World Report honor-roll hospital; and, most recently, it was recognized as a Fortune top-100 place to work. Importantly, in his role at VUMC he participated in the oversight of technology transfer operations that resulted in the creation of over 30 companies.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Harry Jacobson invests in
Stages Harry Jacobson invests in
Countries Harry Jacobson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Music 1 (14%)
- Mobile 1 (14%)
- FinTech 1 (14%)
- Computer 1 (14%)
- Politics 1 (14%)
Stage
- Seed 2 (29%)
- Series A 1 (14%)
- Series C 1 (14%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
icitizen
|
icitizen connects people with their elected officials and the organizations they care about.Using icitizen, people vote on and promote issues and policies that affect their lives.In January 2016, icitizen was relaunched with a broader vision to help citizens, elected officials, candidates, organizations, schools and companies strengthentheir relationships with one another. | $717.5K / Series A / Sep 30, 2014 | |
|
icitizen
|
icitizen connects people with their elected officials and the organizations they care about.Using icitizen, people vote on and promote issues and policies that affect their lives.In January 2016, icitizen was relaunched with a broader vision to help citizens, elected officials, candidates, organizations, schools and companies strengthentheir relationships with one another. | $2.1M / Apr 01, 2014 | |
Seno Medical Instruments
|
Seno Medical was formed to commercialize a new modality in cancer screening and diagnosis: opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Their first product is a small animal imaging device. This productapplication was successfully licensed to a world market leader, VisualSonics. Products for use with humans, focusing initially on breast cancer, are also in development. Seno’s first clinical application is for breast cancer diagnosis.A strong, experienced management team and nationally recognized Scientific Advisory Board have been assembled to complete the commercialization, secure regulatory approval and launch the products. The management team has a long history of working together and in successfully commercializing medical devices.Seno’s patented technology integrates the use of lasers and acoustics to determine the presence of angiogenesis—the growth of blood vessels and higher blood volume that always surrounds a tumor. This represents a significant evolutionary step in imaging. Unlike anatomical imaging techniques, such as mammography, laser opto-acoustic imaging can detect breast cancer, for example, at its earliest clinically significant stage (2 mm. versus 10 mm. with mammography) without patient discomfort or exposure to harmful x-ray.The opportunities are exciting…for investors and scientists, for physicians and the myriad women and men tested for or diagnosed with cancer each year. The goal of laser opto-acoustic imaging is to allow more precise and earlier detection of smaller tumors and the ability to differentiate benign from malignant growth without biopsy. Future applications will focus on other types of cancer and broader diagnostic and treatment applications.Seno acquired working pre-prototypes in addition to the core patents on opto-acoustic technology; they will license two other patents for future applications. These patents constitute a platform technology with a multitude of potential follow-on applications, including imaging for the earliest detection of cancer of the ovary, bladder, prostate, colon and melanoma as well as unstable plaque (cardiovascular).Peer review and the continued funding of $13 million from nationally recognized institutions such as the National Institutes of Health (NIH), National Cancer Institute (NCI) and the Department of Defense (DoD) support their scientific credibility. And, significantly, the pre-prototypes being used in clinical testing have demonstrated a strong correlation to biopsy in diagnosing cancer.They look forward to the future and to the role Seno can play in minimizing the uncertainty, the cost and trauma of diagnosing and treating cancer. | $39M / Series C / Feb 20, 2014 | |
|
icitizen
|
icitizen connects people with their elected officials and the organizations they care about.Using icitizen, people vote on and promote issues and policies that affect their lives.In January 2016, icitizen was relaunched with a broader vision to help citizens, elected officials, candidates, organizations, schools and companies strengthentheir relationships with one another. | $762.5K / Series A / Jan 06, 2014 | |
|
icitizen
|
icitizen connects people with their elected officials and the organizations they care about.Using icitizen, people vote on and promote issues and policies that affect their lives.In January 2016, icitizen was relaunched with a broader vision to help citizens, elected officials, candidates, organizations, schools and companies strengthentheir relationships with one another. | $1M / Seed / Nov 01, 2013 | |
Artist Growth
|
Artist Growth is on a mission to empower every creator and media company with the business tools they need to cultivate success on their terms and move the culture forward with art. Founded in 2012 by independent musician Matt Urmy, Artist Growth’s flagship product, Workspace, has become the essential artist management tool, trusted by the biggestnames in the business, including Warner Music Group and Universal Music Group. Its latest offering, Artist Growth X, is an innovative suite of credit cards created to provide artists and their teams with access to affordable capital when they need it. | $2M / Seed / Mar 15, 2013 | |
|
icitizen
|
icitizen connects people with their elected officials and the organizations they care about.Using icitizen, people vote on and promote issues and policies that affect their lives.In January 2016, icitizen was relaunched with a broader vision to help citizens, elected officials, candidates, organizations, schools and companies strengthentheir relationships with one another. | $1.2M / Seed / Sep 01, 2012 |
Co-Investors
About Epiphany Health Ventures
Epiphany Health Ventures (“EHV”) is an organization specifically designed to enable innovation in the healthcare delivery system through the creation of and investment in highly disruptive healthcare services enterprises. Through a distinct framework designed to access and leverage (i) deep healthcare services domain experience, (ii) highly skilledoperating partner capabilities, and (iii) a differentiated investment philosophy and structure, EHV intends to create transformational healthcare service businesses that will aim to positively impact the medical delivery system by improving the correlation of service delivery costs with outcomes and efficiency in patient care.
Epiphany Health Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Harry Jacobson
Co-Founder and Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Harry Jacobson invest in?
Harry Jacobson invests primarily in Music, Mobile and FinTech startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Harry Jacobson?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Harry Jacobson last invest?
The most recent investment recorded for Harry Jacobson closed in Sep 2014. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
